InvestorsHub Logo

yip

Followers 13
Posts 2189
Boards Moderated 0
Alias Born 08/18/2012

yip

Re: abew4me post# 51345

Thursday, 04/26/2018 5:19:53 PM

Thursday, April 26, 2018 5:19:53 PM

Post# of 58840
Not so abe. Since our Vandalia Research acquisition in Sept 2015, we've broadened our horizons...

The acquisition provides APDN with established supply relationships across key companies in the biotechnology, pharmaceutical and diagnostic markets where Vandalia DNA is already used as a business-critical therapeutic, diagnostic and reagent and provides the company the opportunity to cross-sell its DNA-based supply chain security solutions. There will be no lapse in DNA production as we fulfil Vandalia's current backlog and expected orders through the remainder of the current quarter and beyond.

A new capacity for APDN will be the ability to manufacture longer DNA sequences valuable in gene therapy, DNA vaccines and diagnostics. These types of DNA are distinct from APDN's security markers and represent a new entry into medical markets, where management believes there are ample opportunities for APDN's broader platform.


https://finance.yahoo.com/news/applied-dna-sciences-acquires-assets-172904944.html
additional info on Bulk DNA at:
http://adnas.com/?s=vandalia&lang=en
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APDN News